https://doi.org/10.4081/reumatismo.2018.1039

Comorbidity in polymyalgia rheumatica

Vol. 70 No. 1 (2018): Monographic issue on Polymyalgia Rheumatica
Submitted: 4 July 2017
Accepted: 13 September 2017
Published: 27 March 2018
Polymyalgia rheumatica, Paraneoplastic syndrome, Cancer, Systematic review.
Abstract Views: 3210
PDF: 1940
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

C. Chatzigeorgiou
umcch@leeds.ac.uk
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, United Kingdom.
S.L. Mackie
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, United Kingdom.
Polymyalgia rheumatica (PMR) is the commonest inflammatory rheumatic disease affecting older people. The current mainstay of treatment is long-term oral glucocorticoid therapy. Management of these patients in clinical practice is often complicated by the presence of comorbidity. Comorbidity might be due to shared risk factors such as age, sex, or genetic background; to the presence of the disease itself; or to adverse effects of glucocorticoid therapy. Cardiovascular disease, osteoporosis/fracture, metabolic and ocular comorbidity are of particular interest to clinicians because of their relationship to glucocorticoid therapy and the relevance to clinical treatment decisions regarding glucocorticoid tapering. Patients at high risk of exacerbation of comorbidity by glucocorticoid therapy may be considered for adjunctive steroid-sparing therapies and thus may need specialist management. From a public health perspective, with the ageing population the prevalence of PMR is predicted to increase; accurate data on comorbidity will be needed for planning and delivery of healthcare services.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

Chatzigeorgiou, C., & Mackie, S. (2018). Comorbidity in polymyalgia rheumatica. Reumatismo, 70(1), 35–43. https://doi.org/10.4081/reumatismo.2018.1039

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

Similar Articles

<< < 3 4 5 6 7 8 9 10 11 12 > >> 

You may also start an advanced similarity search for this article.